IP Library Granted Patent US 8,889,179
Granted Patent B2
US 8,889,179 · App. 14/146,744 · Granted Nov 18, 2014

Membrane

Inventors: Peter Coffey (London, GB); Lyndon Da Cruz (London, GB); Karen Cheetham (Hertfordshire, GB)
Assignee: UCL Business PLC
A61K9/0048C12N5/0621A61K35/12C12N2533/30A61L27/3804A61L27/3813A61K35/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,179
App. No.
14/146,744
Granted
Nov 18, 2014
Kind
B2
Abstract

The invention relates to a membrane for supporting cells, especially retinal pigmented epithelial (RPE) cells. The membrane is useful in the treatment of conditions such as age related macular degeneration. The membrane may also be used to support retinal pigmented epithelial cell precursors and retinal cell derivative cells formed from the differentiation of RPE on the membrane.

Claims (19)

1. A composition comprising: (a) a membrane for supporting growth of cells, the membrane being non-biodegradable and porous, wherein pores of said membrane are between approximately 0.3 μm and 0.45 μm diameter, wherein pore density of the membrane is between 1×10 7 and 3×10 8 pores per cm 2 , and (b) a layer of retinal pigment epithelial cells, or retinal pigment epithelial cell precursors, or retinal derivative cells formed from the differentiation of retinal pigment epithelial cells on the membrane.

2. A composition according to claim 1 wherein the membrane hydraulic conductance of the membrane is more than 50×10 −10 in sec −1 Pa −1 .

3. A composition according to claim 1 wherein the membrane is sterilised by gamma irradiation, ethylene oxide, autoclaving or UV sterilization without degrading.

4. A composition according to claim 1 , wherein the membrane is sealed by ultrasonic sealing, radio frequency sealing or insert molding.

5. A composition according to claim 1 , wherein said membrane has a maximum thickness of approximately 11 μm.

6. A composition according to claim 1 , wherein said membrane has a maximum weight of approximately 1.5 mg/cm 2 .

7. A composition according to claim 1 , wherein the membrane is hydrophilic.

8. A composition according to claim 1 , wherein said membrane has a pH of 4 to 8.

9. A composition according to claim 1 , wherein said membrane comprises a coating on at least one side.

10. A composition according to claim 9 , wherein the coating is laminin, matrigel, fibronectin, or PLGA.

11. A composition according to claim 9 , comprising a pharmacological or biological agent, bound to the coating.

12. A composition according to claim 1 , wherein the cells are human retinal pigmented epithelial cells.

13. A composition according to claim 12 , wherein the cells are immortalized cells.

14. A composition according to claim 1 , wherein the membrane is made from a hydrophilic polymer selected from the group consisting of: a polyester, a polyurethane, a polyurea-urethane, a polyamide, a polyether-ester, a polycarbonate, a polyacrylate, poly(tetrafluoroethene), a polysiloxane, a polyolefin, and polyoxymethylene.

15. A method for using a composition according to claim 1 , comprising:

transplanting the membrane into an eye.

16. A composition comprising (a) a membrane for supporting the growth of cells, the membrane being made from a polyester and comprising a substantially no-biodegradable and porous support layer having a maximum thickness of between 9 μm and 11 μm and coated on at least one side with a coating comprising a glycoprotein, the pores being approximately 0.4 μm in diameter, wherein the pore density of the pores in the support layer is approximately 1×10 8 pores per cm 2 ; and (b) a layer of retinal pigment epithelial cells, or retinal pigment epithelial cell precursors, or retinal derivative cells formed from the differentiation of retinal pigment epithelial cells on the membrane.

17. A composition according to claim 14 wherein the hydrophilic polymer is polyester.

18. A composition according to claim 12 wherein the retinal pigment epithelial cells originate from human embryonic stem cells.

Assignments (1)
CHANGE OF NAME Recorded Oct 4, 2022
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD.
Reel/Frame 061596/0772 →
Priority Claims (1)
GB 0806746.4 · Apr 14, 2008 · national
Continuity (2)
Continuation 12933694
Related Publication 20140127282A1 · May 8, 2014